Medicine
Dexamethasone 20 mg/5 mL injection
Dexamethasone 20 mg/5 mL injection is a generic prescription medicine for intra-articular, intralesional, intramuscular, intravenous, soft tissue use, made by 14 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Dexamethasone
- Brand
- Sold under the generic name
- Strength
- 20 mg/5 mL
- Dosage form
- Injection
- Route
- Intra-articular, intralesional, intramuscular, intravenous, soft tissue
- Packs
- 25 vials of 5 mL, 10 vials of 5 mL, 1 vial of 5 mL and 17 more
- Manufacturers
- EugiaIndiaGland PharmaIndiaAsclemedMedical Purchasing SolutionsHealthFirstHikma PharmaceuticalsA-S Medication SolutionsAmneal PharmaceuticalsHenry ScheinMylan Institutional
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A01AC02 Dexamethasone
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 July 1975
- Identifiers
- RxCUI 1116927, 1812079, 1812194 +1DailyMed set ID 69485218-9330-952d-e053-2a91aa0ad4e8, 42c879cc-38dc-c9bc-e063-6294a90a204d, a31b013f-924c-42f8-b8ab-ce60bb8ad7b8 +15NDC 71872-7128, 84549-422, 87063-289 +15Application ANDA206781, ANDA040803, ANDA084282 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 55150-238-05 | EugiaIndia | 1 December 2015 |
| 25 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 68083-474-25 | Gland PharmaIndia | 4 August 2021 |
| 25 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 70121-1451-5 | Amneal Pharmaceuticals | 27 August 2018 |
| 10 vial in 1 carton / 5 mL in 1 vial | 0641-6146-10 | Hikma Pharmaceuticals | 3 October 2023 |
| 25 vial in 1 carton / 5 mL in 1 vial | 0641-6146-25 | Hikma Pharmaceuticals | 15 July 1975 |
| 25 vial in 1 carton / 5 mL in 1 vial | 67457-422-54 | Mylan Institutional | 11 May 2011 |
| 25 vial in 1 carton / 5 mL in 1 vial | 25021-052-05 | Sagent Pharmaceuticals | 1 December 2024 |
| 25 vial, multi-dose in 1 carton / 5 mL in 1 vial, multi-dose | 70069-023-25 | Somerset Therapeutics | 8 June 2018 |
| 1 vial, multi-dose in 1 bag / 5 mL in 1 vial, multi-dose | 71872-7128-1 | Medical Purchasing Solutions | 30 March 2018 |
| 1 vial in 1 bag / 5 mL in 1 vial | 71872-7157-1 | Medical Purchasing Solutions | 11 March 2019 |
| 1 vial in 1 bag / 5 mL in 1 vial | 71872-7347-1 | Medical Purchasing Solutions | 21 April 2025 |
| 25 vial in 1 carton / 5 mL in 1 vial | 76420-397-05 | Asclemed | 31 May 2025 |
| 10 vial in 1 carton / 5 mL in 1 vial | 87063-289-10 | Asclemed | 7 August 2026 |
| 25 vial in 1 carton / 5 mL in 1 vial | 87063-289-25 | Asclemed | 7 August 2026 |
| 5 mL in 1 vial | 51662-1297-1 | HealthFirst | 21 July 2019 |
| 10 pouch in 1 case / 1 vial in 1 pouch / 5 mL in 1 vial | 51662-1660-3 | HealthFirst | 15 July 1975 |
| 2 vial in 1 carton / 5 mL in 1 vial | 50090-2313-2 | A-S Medication Solutions | 23 February 2016 |
| 1 vial in 1 bag / 5 mL in 1 vial | 0404-9805-05 | Henry Schein | 9 December 2024 |
| 5 mL in 1 vial | 84549-422-54 | ProPharma Distribution | 4 November 2025 |
| 25 vial in 1 carton / 5 mL in 1 vial | 85766-216-25 | Sportpharm | 10 July 2026 |
| 25 vial, multi-dose in 1 tray / 5 mL in 1 vial, multi-dose | 63323-165-05 | — | 7 September 2000 |
| 25 vial, multi-dose in 1 tray / 5 mL in 1 vial, multi-dose | 63323-165-26 | — | 7 September 2000 |
| 25 vial, multi-dose in 1 tray / 5 mL in 1 vial, multi-dose | 63323-165-53 | — | 17 February 2025 |
| 5 mL in 1 vial, multi-dose | 51662-1370-1 | — | 13 October 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Dexamethasone 20 mg/5 mL injection.
Other strengths and forms of Dexamethasone
Clinical summary
Dexamethasone is a corticosteroid. It is available as tablets, injection and elixir for oral, intramuscular and intravenous use. MedsAcross supplies Dexamethasone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DexamethasoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- MAXIDEX prescribing information (Harrow Eye) · U.S. National Library of Medicine, DailyMed
- Neofordex: European public assessment report (EPAR) · European Medicines Agency
- Ozurdex: European public assessment report (EPAR) · European Medicines Agency
Need Dexamethasone 20 mg/5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.